Safety and efficacy of transarterial chemoembolization combined with tyrosine kinase inhibitors and camrelizumab in the treatment of patients with advanced unresectable hepatocellular carcinoma

OBJECTIVE: This study was aimed to evaluate the efficacy and safety of transarterial chemoembolization combined with tyrosine kinase inhibitors and camrelizumab in the treatment of unresectable hepatocellular carcinoma and to explore a new therapeutic strategy for the treatment of advanced HCC. PATI...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jinpeng, Kong, Mingxin, Yu, Guangji, Wang, Song, Shi, Zhaozhang, Han, Huihui, Lin, Yanyan, Shi, Jutian, Song, Jinlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401037/
https://www.ncbi.nlm.nih.gov/pubmed/37545497
http://dx.doi.org/10.3389/fimmu.2023.1188308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401037/
https://www.ncbi.nlm.nih.gov/pubmed/37545497
http://dx.doi.org/10.3389/fimmu.2023.1188308

Ejemplares similares